Roucka, M, Zimmermann, K, Fido, M, and Nechansky, A. (2017). Application of lectin array technology for biobetter characterization: its correlation with Fc?RIII binding and ADCC. Microarrays. 6:1.
Zopf, A, Raim, R, Danzer, M, Niklas, N, Spilka, R, Pröll, J, Gabriel, C, Nechansky, A, and Roucka, M. (2015). Introduction of the hybcell-based compact sequencing technology and comparison to state-of-the-art methodologies for KRAS mutation detection. Biotechniques. 58:126-134.
Kircheis, R, Halanek, N, Koller, I, Jost, W, Schuster, M, Gorr, G, Hajszan, K, and Nechansky, A. (2012). Correlation of ADCC activity with cytokine release induced by the stably expressed, glyco-engineered humanized Lewis Y-specific monoclonal antibody MB314. MAbs. 4:532-541.
Nechansky, A, and Kircheis R. (2010). Immunogenicity of therapeutics: a matter of efficacy and safety. Expert Opin. Drug Discov. 5:1-13.
Antes, B, Oberkleiner, P, Nechansky, A, and Szolar, OHJ. (2010). Qualification of a microfluidics-based electrophoretic method for impurity testing of monoclonal antibodies. J. Pharm. Biomed. Anal. 51:743-749.
Nechansky, A. (2010). HAHA - nothing to laugh about. Measuring the immunogenicity (human anti-human antibody response) induced by humanized monoclonal antibodies applying ELISA and SPR technology. J. Pharm. Biomed. Anal. 51:252-254.
Nechansky, A, Szolar, OHJ, Siegl, P, Zinoecker, I, Halanek, I, Wiederkum, S, and Kircheis, R. (2009). Complement dependent cytotoxicity (CDC) activity of a humanized anti Lewis-Y antibody: FACS-based assay versus the 'classical' radioactive method - qualification, comparison and application of the FACS based approach. J. Pharm. Biomed. Anal. 49:1014-1020.
Nechansky, A, Grunt, S, Roitt, I, and Kircheis, R. (2008). Comparison of the calibration standards of three commercially available multiplex kits for human cytokine measurement to WHO standards reveals striking differences. Biomarkers Insight 3:227-235.
Antes, B, Amon, S, Rizzi, A, Wiederkum, S, Kainer, M, Szolar, OHJ, Fido, M, Kircheis, R, and Nechansky, A. (2007). Analysis of lysine clipping of a humanized Lewis-Y specific IgG antibody and its relation to Fc-mediated effector function. J. Chromatography B. 852:250-256.
Szolar, OHJ, Stranner, S, Zinoecker, I, Himmler, G, Waxenecker, G, Mudde, GC, and Nechansky, A. (2006). Qualification and application of a surface plasmon resonance based assay monitoring HAHA responses induced after passive administration of a humanized anti-Lewis-Y antibody. J. Pharm. Biomed. Anal. 41:1347-1353.
For reprints please contact office(at)vela-labs.at